Karim Chkirate
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karim Chkirate has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Joel T. Mague
Department of Chemistry, Tulane University, New Orleans, LA 70118, USA
21 shared publications - El Mokhtar Essassi
Laboratory of Heterocyclic Organic Chemistry, Medicines Science Research Center, Pharmacochemistry Competence Center, Mohammed V University in Rabat, Faculté des Sciences, Av. Ibn Battouta, BP 1014, Rabat, Morocco
14 shared publications - Nada Kheira Sebbar
Laboratory of Heterocyclic Organic Chemistry Medicines Science Research Center Pharmacochemistry Competence Center Mohammed V University in Rabat Faculté des Sciences Av Ibn Battouta BP 1014 Rabat Morocco
8 shared publications El Mokhtar Essassi
7 shared publications- Luc Van Meervelt
Department of Chemistry KU Leuven Leuven Belgium
6 shared publications - Khalid Karrouchi
Laboratory of Analytical Chemistry and Bromatology Team of Formulation and Quality Control of Health Products Faculty of Medicine and Pharmacy Mohammed V University in Rabat Rabat Morocco
5 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 82 (10) , 1154-1159
Crystal structure and Hirshfeld surface analysis of 2,5-dimethyl-1 H -benzo[ d ]imidazole
The title molecule, C 9 H 10 N 2 , exhibits whole-molecule disorder in a 0.849 (4)/0.151 (4) ratio. The bicyclic portion is planar. In the crystal, a layer structure parallel to the ac plane is generated by N—H...N hydrogen bonds and C—H...π(ring) interactions. Hirshfeld surface analysis indicates that the most important contributions to the crystal packing are from H...H, C...H/H...C and N...H/H...N interactions.
- 8 September 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 82 (10) , 1154-1159
Open AccessCrystal structure and Hirshfeld surface analysis of 2,5-dimethyl-1 H -benzo[ d ]imidazole
The title molecule, C 9 H 10 N 2 , exhibits whole-molecule disorder in a 0.849 (4)/0.151 (4) ratio. The bicyclic portion is planar. In the crystal, a layer structure parallel to the ac plane is generated by N—H...N hydrogen bonds and C—H...π(ring) interactions. Hirshfeld surface analysis indicates that the most important contributions to the crystal packing are from H...H, C...H/H...C and N...H/H...N interactions.
- Open Access
Crystallographic Study, Biological Evaluation and Docking/MD/POM Analyses of Isoxazole-Linked Sulfonate Ester Conjugates
In the present study, a series of isoxazole derivatives were severally evaluated for their antifungal activity against the yeast Candida albicans and molds such as Aspergillus niger, Aspergillus flavus, and Fusarium oxysporum. The results demonstrate that the isoxazole derivatives exhibit considerable antifungal potential, particularly isoxazole-sulfonate ester 4b (Ar= 4-(Cl)C6H4, Ar′= 4-(CH3)C6H4), which was found to be active with significant inhibition zones; the diameters of the C. albicans and F. oxysporum samples were measured at 17.00 ± 0.00 mm and 14.00 ± 0.00 mm, respectively. Furthermore, compounds 4a (Ar= 4-(CH3)C6H4, Ar′= 4-(CH3)C6H4), 4c (Ar: 4-(Cl)C6H4, Ar′: 4-(NO2)C6H4) and 4d (Ar: 4-(Cl)C6H4, Ar′: 3-(Cl)-2-(OCH3)C6H3) demonstrated MIC and MFC values of 20 µg/mL against C. albicans. In addition, the anti-hemolytic activity of these derivatives was evaluated. Compounds 4a, 4e (Ar: 4-(Cl)C6H4, Ar′: 3,4-(OCH3)2C6H3) and aroylisoxazole 3a (Ar: 4-(CH3)C6H4) demonstrated a high degree of anti-hemolytic activity (>99%) at all concentrations evaluated (10, 15, and 20 mg/mL). Molecular docking and molecular dynamics studies over 200 ns revealed protein–ligand complexes to have high affinity and stability, which agrees with the experimental results. The compounds 4d, 4e, and 3a have shown significant interaction with the target proteins of C. albicans, A. flavus, and F. oxysporum, respectively. The results have revealed that the major interaction sites are hydrogen bonding, hydrophobic interactions, and the presence of a water molecule, especially with key residues like TYR_84, ASP_120, SER_90, and THR_89. The crystal structure of compound 4a was also obtained.
Open AccessCrystallographic Study, Biological Evaluation and Docking/MD/POM Analyses of Isoxazole-Linked Sulfonate Ester Conjugates
In the present study, a series of isoxazole derivatives were severally evaluated for their antifungal activity against the yeast Candida albicans and molds such as Aspergillus niger, Aspergillus flavus, and Fusarium oxysporum. The results demonstrate that the isoxazole derivatives exhibit considerable antifungal potential, particularly isoxazole-sulfonate ester 4b (Ar= 4-(Cl)C6H4, Ar′= 4-(CH3)C6H4), which was found to be active with significant inhibition zones; the diameters of the C. albicans and F. oxysporum samples were measured at 17.00 ± 0.00 mm and 14.00 ± 0.00 mm, respectively. Furthermore, compounds 4a (Ar= 4-(CH3)C6H4, Ar′= 4-(CH3)C6H4), 4c (Ar: 4-(Cl)C6H4, Ar′: 4-(NO2)C6H4) and 4d (Ar: 4-(Cl)C6H4, Ar′: 3-(Cl)-2-(OCH3)C6H3) demonstrated MIC and MFC values of 20 µg/mL against C. albicans. In addition, the anti-hemolytic activity of these derivatives was evaluated. Compounds 4a, 4e (Ar: 4-(Cl)C6H4, Ar′: 3,4-(OCH3)2C6H3) and aroylisoxazole 3a (Ar: 4-(CH3)C6H4) demonstrated a high degree of anti-hemolytic activity (>99%) at all concentrations evaluated (10, 15, and 20 mg/mL). Molecular docking and molecular dynamics studies over 200 ns revealed protein–ligand complexes to have high affinity and stability, which agrees with the experimental results. The compounds 4d, 4e, and 3a have shown significant interaction with the target proteins of C. albicans, A. flavus, and F. oxysporum, respectively. The results have revealed that the major interaction sites are hydrogen bonding, hydrophobic interactions, and the presence of a water molecule, especially with key residues like TYR_84, ASP_120, SER_90, and THR_89. The crystal structure of compound 4a was also obtained.
- Open Access
- 1 January 2026
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2026 (1)
Phytochemistry and Antioxidant, Antimicrobial, and Antidiabetic Potentials of Myrtus communis L. Essential Oil Through In Vitro and In Silico Tests
Aim: Myrtus communis is a medicinal plant known for its pharmacological potential against cardiovascular, metabolic, and infectious disorders. This study aimed to analyze the phytochemical composition of Myrtus communis essential oil (MCEO) and to evaluate its antioxidant, antimicrobial, and antidiabetic activities through in vitro and in silico approaches. Methods: The chemical profile of MCEO was determined by gas chromatography–mass spectrometry (GC–MS). Antioxidant activity was assessed using DPPH and FRAP assays. Antimicrobial activity was evaluated against Gram‐positive bacteria ( Bacillus subtilis and Staphylococcus aureus ), Gram‐negative bacteria ( Escherichia coli and Pseudomonas aeruginosa ), and yeasts ( Candida albicans and Candida krusei ) using the broth microdilution method. Antidiabetic activity was tested by measuring the inhibition of α‐amylase and α‐glucosidase. To complete the experimental results, ADMET and molecular docking analyses were performed. Results: GC–MS analysis identified 1,8‐cineole (54.84%), p ‐cymene (19.42%), and β‐pinene (4.66%) as the major constituents of MCEO. The oil exhibited notable antioxidant activity, showing free radical scavenging in the DPPH assay and strong reducing capacity in the FRAP assay. Antimicrobial testing revealed significant effects against all strains, with minimum inhibitory concentrations (MICs) ranging from 0.019% to 0.312% (v/v) for bacteria and from 0.019% to 0.078% (v/v) for fungi, suggesting potential bactericidal and fungicidal properties. Furthermore, MCEO demonstrated moderate inhibitory activity on α‐amylase (IC 50 = 0.179 ± 0.091 mg/mL) and a statistically significant but lower inhibition of α‐glucosidase (IC 50 = 0.086 ± 0.017 mg/mL, p < 0.001). Conclusion: The results indicate that MCEO possesses promising antioxidant, antimicrobial, and moderate in vitro α‐amylase and α‐glucosidase inhibitory activity. These findings suggest its potential as a natural source for the development of new pharmacological agents.
- 1 January 2026
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2026 (1)
Open AccessPhytochemistry and Antioxidant, Antimicrobial, and Antidiabetic Potentials of Myrtus communis L. Essential Oil Through In Vitro and In Silico Tests
Aim: Myrtus communis is a medicinal plant known for its pharmacological potential against cardiovascular, metabolic, and infectious disorders. This study aimed to analyze the phytochemical composition of Myrtus communis essential oil (MCEO) and to evaluate its antioxidant, antimicrobial, and antidiabetic activities through in vitro and in silico approaches. Methods: The chemical profile of MCEO was determined by gas chromatography–mass spectrometry (GC–MS). Antioxidant activity was assessed using DPPH and FRAP assays. Antimicrobial activity was evaluated against Gram‐positive bacteria ( Bacillus subtilis and Staphylococcus aureus ), Gram‐negative bacteria ( Escherichia coli and Pseudomonas aeruginosa ), and yeasts ( Candida albicans and Candida krusei ) using the broth microdilution method. Antidiabetic activity was tested by measuring the inhibition of α‐amylase and α‐glucosidase. To complete the experimental results, ADMET and molecular docking analyses were performed. Results: GC–MS analysis identified 1,8‐cineole (54.84%), p ‐cymene (19.42%), and β‐pinene (4.66%) as the major constituents of MCEO. The oil exhibited notable antioxidant activity, showing free radical scavenging in the DPPH assay and strong reducing capacity in the FRAP assay. Antimicrobial testing revealed significant effects against all strains, with minimum inhibitory concentrations (MICs) ranging from 0.019% to 0.312% (v/v) for bacteria and from 0.019% to 0.078% (v/v) for fungi, suggesting potential bactericidal and fungicidal properties. Furthermore, MCEO demonstrated moderate inhibitory activity on α‐amylase (IC 50 = 0.179 ± 0.091 mg/mL) and a statistically significant but lower inhibition of α‐glucosidase (IC 50 = 0.086 ± 0.017 mg/mL, p < 0.001). Conclusion: The results indicate that MCEO possesses promising antioxidant, antimicrobial, and moderate in vitro α‐amylase and α‐glucosidase inhibitory activity. These findings suggest its potential as a natural source for the development of new pharmacological agents.
- 17 August 2024
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1320
Deciphering the cytotoxic and antioxidant potential of 3,5-disubstituted isoxazole-linked benzimidazolone derivatives
- 17 August 2024
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1320
Deciphering the cytotoxic and antioxidant potential of 3,5-disubstituted isoxazole-linked benzimidazolone derivatives
- Open Access
Efficient Synthesis, Structural Characterization, Antibacterial Assessment, ADME-Tox Analysis, Molecular Docking and Molecular Dynamics Simulations of New Functionalized Isoxazoles
This work describes the synthesis, characterization, and in vitro and in silico evaluation of the biological activity of new functionalized isoxazole derivatives. The structures of all new compounds were analyzed by IR and NMR spectroscopy. The structures of 4c and 4f were further confirmed by single crystal X-ray and their compositions unambiguously determined by mass spectrometry (MS). The antibacterial effect of the isoxazoles was assessed in vitro against Escherichia coli, Bacillus subtilis, and Staphylococcusaureus bacterial strains. Isoxazole 4a showed significant activity against E. coli and B. subtilis compared to the reference antibiotic drugs while 4d and 4f also exhibited some antibacterial effects. The molecular docking results indicate that the synthesized compounds exhibit strong interactions with the target proteins. Specifically, 4a displayed a better affinity for E. coli, S. aureus, and B. subtilis in comparison to the reference drugs. The molecular dynamics simulations performed on 4a strongly support the stability of the ligand–receptor complex when interacting with the active sites of proteins from E. coli, S. aureus, and B. subtilis. Lastly, the results of the Absorption, Distribution, Metabolism, Excretion and Toxicity Analysis (ADME-Tox) reveal that the molecules have promising pharmacokinetic properties, suggesting favorable druglike properties and potential therapeutic agents.
Open AccessEfficient Synthesis, Structural Characterization, Antibacterial Assessment, ADME-Tox Analysis, Molecular Docking and Molecular Dynamics Simulations of New Functionalized Isoxazoles
This work describes the synthesis, characterization, and in vitro and in silico evaluation of the biological activity of new functionalized isoxazole derivatives. The structures of all new compounds were analyzed by IR and NMR spectroscopy. The structures of 4c and 4f were further confirmed by single crystal X-ray and their compositions unambiguously determined by mass spectrometry (MS). The antibacterial effect of the isoxazoles was assessed in vitro against Escherichia coli, Bacillus subtilis, and Staphylococcusaureus bacterial strains. Isoxazole 4a showed significant activity against E. coli and B. subtilis compared to the reference antibiotic drugs while 4d and 4f also exhibited some antibacterial effects. The molecular docking results indicate that the synthesized compounds exhibit strong interactions with the target proteins. Specifically, 4a displayed a better affinity for E. coli, S. aureus, and B. subtilis in comparison to the reference drugs. The molecular dynamics simulations performed on 4a strongly support the stability of the ligand–receptor complex when interacting with the active sites of proteins from E. coli, S. aureus, and B. subtilis. Lastly, the results of the Absorption, Distribution, Metabolism, Excretion and Toxicity Analysis (ADME-Tox) reveal that the molecules have promising pharmacokinetic properties, suggesting favorable druglike properties and potential therapeutic agents.
- Open Access
- 26 March 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 80 (4) , 430-434
Crystal structure and Hirshfeld surface analysis of ethyl 2-(7-chloro-3-methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)acetate
The quinoxaline moiety in the title molecule, C13H13ClN2O3, is almost planar (r.m.s. deviation of the fitted atoms = 0.033 Å). In the crystal, C—H...O hydrogen bonds plus slipped π-stacking and C—H...π(ring) interactions generate chains of molecules extending along the b-axis direction. The chains are connected by additional C—H...O hydrogen bonds. Hirshfeld surface analysis indicates that the most important contributions to the crystal packing are from H...H (37.6%), H...O/O...H (22.7%) and H...Cl/Cl...H (13.1%) interactions.
- 26 March 2024
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 80 (4) , 430-434
Open AccessCrystal structure and Hirshfeld surface analysis of ethyl 2-(7-chloro-3-methyl-2-oxo-1,2-dihydroquinoxalin-1-yl)acetate
The quinoxaline moiety in the title molecule, C13H13ClN2O3, is almost planar (r.m.s. deviation of the fitted atoms = 0.033 Å). In the crystal, C—H...O hydrogen bonds plus slipped π-stacking and C—H...π(ring) interactions generate chains of molecules extending along the b-axis direction. The chains are connected by additional C—H...O hydrogen bonds. Hirshfeld surface analysis indicates that the most important contributions to the crystal packing are from H...H (37.6%), H...O/O...H (22.7%) and H...Cl/Cl...H (13.1%) interactions.